Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Documentation on atrial septal defect, sinus venosus type, is limited primarily due to its rarity and the challenges in conducting systematic clinical studies. As this condition affects a relatively small population, comprehensive data collection and research have been constrained. Additionally, the complexity of congenital heart defects often leads to overlapping phenotypes, making it difficult to isolate specific characteristics of this subtype.
The clinical picture of atrial septal defect, sinus venosus type, includes several key features. Patients often experience a left-to-right shunt, which can cause symptoms such as palpitations (30-79% of patients), exertional dyspnea (30-79%), and fatigue (30-79%). Other notable symptoms include exercise intolerance, systolic heart murmur, and cardiac conduction abnormalities, with some patients showing paradoxical splitting of the second heart sound. Anomalous pulmonary venous return is also a common finding.
To navigate your care effectively, consider consulting a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. You may also want to explore clinical trial opportunities to access new treatments. For additional resources, visit the National Organization for Rare Disorders (NORD) at rarediseases.org, which provides information on rare diseases and potential support networks. While there are currently no patient organizations specifically identified for this condition, connecting with broader congenital heart defect communities may offer valuable support.
Currently, there is one active clinical trial related to atrial septal defect, sinus venosus type. This trial is exploring potential interventions to improve outcomes for patients with this condition. For more information on ongoing studies, you can visit the ClinicalTrials.gov search page at https://clinicaltrials.gov/search?cond=atrial%20septal%20defect%2C%20sinus%20venosus%20type. Participation in clinical trials can provide access to cutting-edge treatments and contribute to advancing research.
Actionable guidance for navigating care for atrial septal defect, sinus venosus type
To navigate your care effectively, consider consulting a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. You may also want to explore clinical trial opportunities to access new treatments. For additional resources, visit the National Organization for Rare Disorders (NORD) at rarediseases.org, which provides information on rare diseases and potential support networks. While there are currently no patient organizations specifically identified for this condition, connecting with broader congenital heart defect communities may offer valuable support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.